Close

MedMinder Appoints David J. Shulkin, M.D. Chairman of the Board of Directors

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

MedMinder Systems Inc., the leading fully integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients, announced the appointment of David J. Shulkin, M.D. as Chairman of the Board of Directors (the “Board”).

A well-respected American physician and government official, Dr. Shulkin previously served as U.S. Secretary of Veterans Affairs and Under Secretary of Veterans Affairs for Health in the Trump and Obama Administrations, respectively. Dr. Shulkin also held numerous executive roles at Morristown Medical Center, Atlantic Health System, Beth Israel Medical Center, Temple University Hospital, Drexel University School of Medicine, Medical College of Pennsylvania and University of Pennsylvania Health System. Dr. Shulkin has been named one of the Top 100 Physician Leaders of Hospitals and Health Systems by Becker’s Hospital Review and one of the 50 Most Influential Physician Executives in the Country by Modern Healthcare and Modern Physician.

“We are pleased to welcome David to the Board and are confident that his unparalleled experience across the medical and public health fields will be highly valuable to our rapidly growing Company and network of stakeholders,” said Eran Shavelsky, founder and CEO of MedMinder. “David’s appointment signifies an inflection point in MedMinder’s maturation, and we look forward to leveraging his expertise as we continue to expand our business and enhance the patient, clinician and pharmacy experience.”

Dr. Shulkin commented: “I am honored to lead the Board of MedMinder, an outstanding and innovative Company deeply committed to improving the lives of chronically ill and elderly patients through innovative pharmacy and remote monitoring solutions. Eran has set a solid foundation for the Company and I am excited to work with him and my fellow directors to increase MedMinder’s customer and technology-enabled solutions for years to come.”

Dr. Rafael Torgovicky, General Partner at Accelmed Partners, a lead investor in MedMinder, concluded: “David’s distinguished career, dedication to patient safety and real expertise in advancing quality of care will serve MedMinder well as we continue to execute on the Company’s growth strategy across the U.S.”

About MedMinder Systems Inc.

MedMinder is the leading fully integrated, end-to-end pharmacy, medication adherence and connected care solution for elderly and polypharmacy patients. Founded in 2007 by Eran Shavlelsky, MedMinder currently employs over 100 team members between its Massachusetts and New York locations and is a recognized ultra-high-growth digital healthcare company. MedMinder’s touch screen-enabled, automatic pill dispenser is the first device on the market capable of delivering medications from its pharmacy directly to patients’ doors in pre-organized daily trays for the entire month. With a customer-first approach, MedMinder is continually innovating to improve and meet the evolving needs of patients, caregivers, practitioners and payors.

About Accelmed Partners

Accelmed is a U.S.-based private equity firm focused on acquiring and investing in U.S. commercial stage, lower market HealthTech companies. Since 2009, Accelmed has deployed over $400 million into companies spanning medical devices, diagnostics, digital health and technology-enabled healthcare services. Accelmed seeks to accelerate value and scale innovation across the HealthTech field by bringing to bear the team’s industry experience, operational and financial expertise, and strong global relationships.

Latest stories

Related stories

Alexion and DHL Partner for 100% Sustainable Aviation Fuel

Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL...

Why Early Intervention Is Key To Managing Chronic Health Concerns

Proactive health management is essential for maintaining a good...

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back